会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Injectable bone regeneration gel containing bone formation enhancing peptide
    • 含有骨形成增强肽的可注射骨再生凝胶
    • US08546529B2
    • 2013-10-01
    • US12663399
    • 2008-06-05
    • Chong-Pyoung ChungYoon-Jeong ParkJue-Yeon Lee
    • Chong-Pyoung ChungYoon-Jeong ParkJue-Yeon Lee
    • C07K7/00C07K7/06C07K7/08C07K14/00A61K38/00
    • A61L27/52A61L27/227A61L27/50A61L27/54A61L2300/25A61L2400/06A61L2430/02
    • The present invention relates to an injectable bone regeneration material containing a bone formation enhancing peptide, and more particularly, to an injectable bone regeneration material, in which a bone formation enhancing peptide essentially containing one and more amino acid sequences among SEQ ID NO: 1 to SEQ ID NO: 28 is bonded or mixed to a gel-forming base material selected from the group consisting of chitosan, alginic acid, silk fibroin, propylene glycol, propylene glycol alginic acid, poloxamer, chondroitin sulphate, and the combination thereof. The injectable bone regeneration material according to the present invention can increase differentiation of bone marrow stromal cells and osteoblasts into bone tissue, thus maximizing tissue regeneration by a peptide capable of promoting differentiation of bone tissue and periodontal tissue regeneration. The injectable bone regeneration material is in the form of a gel, and thus can be applied to a surface of various medical devices such as implant etc., and can be mixed with bone graft particles to apply, so that it can increase a treatment effect of existing medical devices to maximize a tissue regeneration effect.
    • 本发明涉及含有骨形成增强肽的可注射骨再生材料,更具体地,涉及可注射骨再生材料,其中,基本上含有SEQ ID NO:1至 SEQ ID NO:28被结合或混合到选自壳聚糖,藻酸,丝素蛋白,丙二醇,丙二醇藻酸,泊洛沙姆,硫酸软骨素及其组合中的凝胶形成基材。 根据本发明的可注射骨再生材料可以增加骨髓基质细胞和成骨细胞分化成骨组织,从而通过能够促进骨组织分化和牙周组织再生的肽最大化组织再生。 可注射骨再生材料为凝胶形式,因此可以应用于诸如植入物等各种医疗装置的表面,并且可以与骨移植物颗粒混合使用,从而可以增加治疗效果 的现有医疗装置以最大化组织再生效果。
    • 2. 发明申请
    • DENTAL CLEANSER COMPOSITION FOR IMPROVING ADHESION TO TEETH
    • 牙齿清洁剂组合物,用于改善粘合剂对牙齿的影响
    • US20130224128A1
    • 2013-08-29
    • US13581073
    • 2011-02-28
    • Chong-Pyoung ChungYoon-Jeong ParkJue-Yeon Lee
    • Chong-Pyoung ChungYoon-Jeong ParkJue-Yeon Lee
    • A61K6/00
    • A61K6/0035A61K8/39A61K8/64A61K8/731A61Q11/00A61Q17/005
    • The present invention relates to a dental cleanser composition for improving adhesion to teeth, and more particularly to, a dental cleanser composition which functions to remove not only a smear layer from the dentin surface of an exposed tooth root, but also oral bacteria, and thus is effective in improving adhesion to teeth in periodontal surgery. The present invention provides a dental cleanser composition containing sodium ethylene diaminotetraacetate and octyl phenol ethoxylate which is a surfactant. Sodium ethylene diaminotetraacetate in the composition functions to remove a smear layer on the tooth root surface and has antibacterial activity, and octyl phenol ethoxylate in the composition functions to lipopolysaccharide. Thus, the composition improves adhesion to teeth in periodontal surgery.
    • 本发明涉及一种牙齿清洁剂组合物,其用于改善与牙齿的粘附性,更具体地说,涉及一种牙科清洁剂组合物,其不仅能够从暴露的牙根的牙本质表面除去涂抹层,而且还可以口服细菌, 有效改善牙周牙周围牙根的粘连。 本发明提供一种含有乙二胺四乙酸钠和辛基酚乙氧基化物的牙科清洁剂组合物,其是表面活性剂。 组合物中的乙二胺四乙酸钠起到除去牙根表面上的涂抹层的作用,具有抗菌活性,并且组合物中的辛基酚乙氧基化物对脂多糖起作用。 因此,该组合物在牙周手术中改善对牙齿的粘附性。
    • 3. 发明授权
    • Bone graft and scaffolding materials immobilized with type I collagen binding peptides
    • 用I型胶原结合肽固定的骨移植物和脚手架材料
    • US08349804B2
    • 2013-01-08
    • US12278009
    • 2007-01-19
    • Yoon-Jeong ParkChong-Pyoung ChungSeung-Jin LeeJue-Yeon Lee
    • Yoon-Jeong ParkChong-Pyoung ChungSeung-Jin LeeJue-Yeon Lee
    • A61K38/10A61K38/16
    • A61L27/10A61L27/34A61L27/54A61L2430/02
    • The present invention relates to a pharmaceutical composition comprising a bone graft material, a scaffold for tissue engineering applications and type I collagen Binding Peptides which have bone calcification-promoting peptides immobilized on the surface, and more particularly, to a bone graft material and a scaffold for tissue engineering applications (hereinafter, referred to as scaffold), which have peptides specifically binding with type I collagen immobilized on the surface, and pharmaceutical composition for recovering tissue regeneration containing type I collagen binding-inducing peptide. In the inventive bone graft material and scaffold for tissue engineering applications, the cells related to regeneration by collagen binding-inducing peptide adhered to the surface, promote an adhesion of type I collagen binding-inducing peptide (main ingredients of extracellular matrix) to increase differentiation rate into bone tissues, and promote a calcification which is last step of bone regeneration to maximize a tissue regeneration finally.
    • 本发明涉及一种药物组合物,其包含骨移植材料,用于组织工程应用的支架和具有固定在表面上的骨钙化促进肽的I型胶原结合肽,更具体地涉及骨移植材料和支架 用于组织工程应用(以下称为支架),其具有与固定在表面上的I型胶原特异性结合的肽,以及用于回收含有I型胶原结合诱导肽的组织再生的药物组合物。 在用于组织工程应用的本发明的骨移植物材料和支架中,与通过胶原结合诱导肽再生的细胞粘附到表面上,促进I型胶原结合诱导肽(细胞外基质的主要成分)的粘附以增加分化 进入骨组织,并促进钙化,这是骨再生的最后一步,最终最大限度地发挥组织再生。
    • 8. 发明申请
    • TARGET-ACTIVATED CELL/TISSUE-PENETRATING PEPTIDE FOR DELIVERY OF IMPERMEABLE COMPOUNDS AND USE THEREOF
    • 用于递送不可化合物的靶向活化细胞/组织渗透肽及其用途
    • US20120053129A1
    • 2012-03-01
    • US13202317
    • 2010-02-19
    • Yoon-Jeong ParkChong-Pyoung ChungVictor C. Yang
    • Yoon-Jeong ParkChong-Pyoung ChungVictor C. Yang
    • A61K38/02A61P37/04A61P35/00A61P29/00C07K19/00C12N9/96
    • C07K14/47A61K38/00A61K47/645A61K47/65C07K2319/10
    • The present invention relates to a target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds (Target Activated Cell/tissue Translocation peptide for Impermeable Compound Strategy (TACTICS)), and the use thereof, and more particularly to a target-activated cell/tissue-penetrating peptide, which comprises (a) a protein transduction domain (PTD), (b) a masking domain and (c) a spacer having a cleavage site specific for a target cell/tissue enzyme and is provided with target selectivity so as to penetrate specifically into a target tissue, and to a conjugate of the peptide with a drug or drug-containing particles for imaging or therapeutic applications. Because the target-activated cell/tissue-penetrating peptide has target selectivity, the peptide-drug conjugate exhibits maximized imaging and therapeutic effects, and the non-specific distribution of the conjugate in vivo is inhibited, so that the side effects of the conjugate are minimized, the diagnostic effects of the conjugate are maximized, and the conjugate is useful for the treatment of disease.
    • 本发明涉及用于递送不可渗透化合物的靶激活细胞/组织穿透肽(用于不透水复合策略的靶活化细胞/组织易位肽(TACTICS))及其用途,更具体地涉及靶激活 细胞/组织穿透肽,其包含(a)蛋白转导结构域(PTD),(b)掩蔽结构域和(c)具有针对靶细胞/组织酶特异性切割位点的间隔物,并提供靶标选择性 以便特异性地穿透靶组织,以及肽与药物或药物的颗粒的缀合物用于成像或治疗应用。 由于目标激活的细胞/组织穿透肽具有靶选择性,所以肽 - 药物缀合物表现出最大化的成像和治疗效果,并且体内缀合物的非特异性分布被抑制,使得缀合物的副作用为 最小化,缀合物的诊断效果最大化,并且缀合物可用于治疗疾病。